Search Results - "Haciefendi, Ayten"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Mechanisms of abemaciclib, a CDK4/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro by Guney Eskiler, Gamze, Deveci Ozkan, Asuman, Haciefendi, Ayten, Bilir, Cemil

    Published in Translational oncology (01-01-2022)
    “…•ABE treatment may be a promising treatment strategy in especially mCRPC.•ABE treatment significantly inhibited PC cell growth through apoptosis,…”
    Get full text
    Journal Article
  2. 2

    Novel combination treatment of CDK 4/6 inhibitors with PARP inhibitors in triple negative breast cancer cells by Guney Eskiler, Gamze, Ozman, Zeynep, Haciefendi, Ayten, Cansaran-Duman, Demet

    “…Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors provide promising results for treating hormone receptor-positive breast cancer. However, the efficacy of CDK4/6…”
    Get full text
    Journal Article
  3. 3

    The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells by Haciefendi, Ayten, Guney Eskiler, Gamze

    Published in American journal of translational research (01-01-2023)
    “…Genomic instability in cancer cells is based on the aberrant activation of deoxyribonucleic acid (DNA) damage response and repair mechanisms. Targeting Ataxia…”
    Get full text
    Journal Article
  4. 4

    The ATR inhibition by Elimusertib enhances the radiosensitivity of MDA-MB-231 triple negative breast cancer in vitro by Guney Eskiler, Gamze, Halis, Hatice, Hamarat, Kaan Furkan, Derlioglu, Rabia Rana, Ugurlu, Berat Tugrul, Haciefendi, Ayten

    Published in International journal of radiation biology (03-05-2024)
    “…DNA damage response (DDR) is the principal mechanism regulating genomic stability and cell cycle checkpoint activation by coordinating DNA repair and apoptotic…”
    Get full text
    Journal Article
  5. 5